United Kingdom · Series D startup
Funding summaryUpdated 26 Oct 2026
$33Mraised across 7 rounds since 2013, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Eagle Genomics filed 4 raises, $28M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Innovate UK
Future Planet Capital
ACF Investors
ETF Partners
EIS Angel Co-InvestmentEnvironmental Technologies FundRainbow Seed FundJonathan MilnerMissing a round, or an investor who was in one? Tell us.
This firm lists Eagle Genomics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Eagle Genomics's investors include Innovate UK, Future Planet Capital, ACF Investors, ETF Partners and EIS Angel Co-Investment, and 3 more on record.
Eagle Genomics has raised $33M across 7 rounds since 2013.
Eagle Genomics's most recent round was a Series D of $784K in Dec 2023.
Eagle Genomics's largest round on record is $21M (Series B), in Oct 2022.
Eagle Genomics's first round on record, in Nov 2013, was backed by Rainbow Seed Fund.
Eagle Genomics's latest named round is a Series D, in Dec 2023.
Eagle Genomics is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
